Similar articles

• [Pioglitazone effects on blood pressure in patients with metabolic syndrome].

  Takahashi A, Kushiro T. Takahashi A, et al. Nihon Rinsho. 2008 Aug;66(8):1591-5. Nihon Rinsho. 2008. PMID: 18700562 Review. Japanese.
• Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial.

  Smith SR, De Jonge L, Volaufova J, Li Y, Xie H, Bray GA. Smith SR, et al. Metabolism. 2005 Jan;54(1):24-32. doi: 10.1016/j.metabol.2004.07.008. Metabolism. 2005. PMID: 15562376 Clinical Trial.
• Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.

  Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, Umeno Y, Okada K, Wakasugi K, Yonemochi H, Eshima N, Saikawa T, Yoshimatsu H. Anan F, et al. Eur J Clin Invest. 2007 Sep;37(9):709-14. doi: 10.1111/j.1365-2362.2007.01854.x. Eur J Clin Invest. 2007. PMID: 17696960
• Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone.

  Sacks HS, Fain JN, Cheema P, Bahouth SW, Garrett E, Wolf RY, Wolford D, Samaha J. Sacks HS, et al. Diabetes Care. 2011 Mar;34(3):730-3. doi: 10.2337/dc10-2083. Epub 2011 Feb 2. Diabetes Care. 2011. PMID: 21289232 Free PMC article.
• Clinical trials with thiazolidinediones in subjects with Type 2 diabetes--is pioglitazone any different from rosiglitazone?

  Doggrell SA. Doggrell SA. Expert Opin Pharmacother. 2008 Feb;9(3):405-20. doi: 10.1517/14656566.9.3.405. Expert Opin Pharmacother. 2008. PMID: 18220491 Review.